FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to pharmacology, namely to a composition of antioxidants exhibiting antiviral activity against tick-borne encephalitis viruses and herpes simplex type 1. Composition is a mixture of echinochrome A, ascorbic acid and α-tocopherol at weight ratio of components of 5:5:1.
EFFECT: disclosed composition is highly effective virucidal and moderately effective virus-inducing agent.
1 cl, 1 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING ANTIVIRAL ACTION AGAINST TICK-BORNE ENCEPHALITIS VIRUSES AND HERPES SIMPLEX TYPE I | 2018 |
|
RU2697887C1 |
ANTIVIRAL AGENT AGAINST HERPES SIMPLEX VIRUS TYPE 1 | 2022 |
|
RU2782935C1 |
ANTIVIRAL AGENT AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2022 |
|
RU2798102C1 |
ANTIVIRAL AGENT AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2022 |
|
RU2812292C1 |
ANTIOXIDANTS COMPOSITION SUITABLE FOR ORAL ADMINISTRATION IN THERAPY OF INFLAMMATORY PROCESS IN LUNGS | 2018 |
|
RU2684783C1 |
ANTIVIRAL AGENT AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2022 |
|
RU2809094C1 |
MEANS FOR FORMATION OF MEDICINE FOR CURING TICK-BORNE ENCEPHALITIS | 2016 |
|
RU2651777C1 |
MEANS FOR PROTECTING THE SKIN FROM PHOTOAGING | 2022 |
|
RU2790820C1 |
NEW DOSAGE FORM OF ECHINOCHROME A, A METHOD OF ITS PREPARATION AND USE | 2022 |
|
RU2800382C1 |
ANTIVIRAL AGENT AGAINST HUMAN HERPESVIRUS TYPE I AND ENTEROVIRUS B | 2022 |
|
RU2798659C1 |
Authors
Dates
2019-08-21—Published
2018-08-06—Filed